47 -9 (83) 2025 - Madina N.E. - PROGNOSTIC METHOD OF PREDICTING THE DEVELOPMENT OF SYSTEMIC INFLAMMATORY RESPONSE IN CHILDREN OF THE FIRST YEAR OF LIFE

PROGNOSTIC METHOD OF PREDICTING THE DEVELOPMENT OF SYSTEMIC INFLAMMATORY RESPONSE IN CHILDREN OF THE FIRST YEAR OF LIFE

Madina N.E. - Department of Hospital Pediatrics, Traditional Medicine, Tashkent Government Medical University

Resume

Systemic inflammatory response syndrome (SIRS) is a life-threatening condition with nonspecific symptoms. As a result, identifying targeted therapies for SIRS in children and adults remains a challenge. In children of the first year of life, due to anatomic-physiologic and immunologic peculiarities, SIRS proceeds according to special clinical and laboratory scenarios, different from those in adults and even in older children. The problem of early diagnosis and appropriate correction of SIRS in infants is of high clinical significance, as this condition may be the first manifestation of sepsis, necrotizing enterocolitis, congenital infections and other life-threatening diseases. At the same time, nonspecificity of symptoms, limited severity of fever and other signs of inflammation complicate early diagnosis.

Key words: systemic inflammatory response syndrome,D-dimer test, sepsis.

First page

292

Last page

295

For citation:Madina N.E. - PROGNOSTIC METHOD OF PREDICTING THE DEVELOPMENT OF SYSTEMIC INFLAMMATORY RESPONSE IN CHILDREN OF THE FIRST YEAR OF LIFE//New Day in Medicine 9(83)2025 292-295 https://newdayworldmedicine.com/en/new_day_medicine/9-83-2025

List of References

1. Markwart, R.; Saito, H.; Harder, T.; Tomczyk, S.; Cassini, A.; Fleischmann-Struzek, C.; Reichert, F.; Eckmanns, T.; Allegranzi, B. Epidemiology and burden of sepsis acquired in hospitals and intensive care units: A systematic review and meta-analysis. // Intensive Care Med. 2020;46:1536–1551.
2. Agnello, L.; Bivona, G.; Parisi, E.; Lucido, G.D.; Iacona, A.; Ciaccio, A.M.; Giglio, R.V.; Ziino, O.; Ciaccio, M. Presepsin and Midregional Proadrenomedullin in Pediatric Oncologic Patients with Febrile Neutropenia. // Lab. Med. 2020;51:585-591.
3. Velissaris, D.; Zareifopoulos, N.; Karamouzos, V.; Karanikolas, E.; Pierrakos, C.; Koniari, I.; Karanikolas, M. Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis. // Cureus 2021;13: e15019.
4. Bone, R.C.; Balk, R.A.; Cerra, F.B.; Dellinger, R.P.; Fein, A.M.; Knaus, W.A.; Schein, R.M.; Sibbald, W.J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. // Chest 1992;101:1644–1655.
5. Singer, M.; Deutschman, C.S.; Seymour, C.W.; Shankar-Hari, M.; Annane, D.; Bauer, M.; Bellomo, R.; Bernard, G.R.; Chiche, J.D.; Coopersmith, C.M.; et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). // JAMA 2016;315:801-810.
6. Brady, J.; Horie, S.; Laffey, J.G. Role of the adaptive immune response in sepsis. // Intensive Care Med. Exp. 2020;8:20.
7. Shashikumar, S.P.; Stanley, M.D.; Sadiq, I.; Li, Q.; Holder, A.; Clifford, G.D.; Nemati, S. Early sepsis detection in critical care patients using multiscale blood pressure and heart rate dynamics. // J. Electrocardiol. 2017;50:739-743.
8. Kataria Y.; Remick D. Sepsis Biomarkers. Methods Mol. Biol. 2021; 2321:177-189.
9. Bellia, C.; Agnello, L.; Lo Sasso, B.; Bivona, G.; Raineri, M.S.; Giarratano, A.; Ciaccio, M. Mid-regional pro-adrenomedullin predicts poor outcome in non-selected patients admitted to an intensive care unit. Clin. Chem. // Lab. Med. 2019;57:549-555.
10. Yipp, B.G.; Winston, B.W. Sepsis without SIRS is still sepsis. // Ann. Transl. Med. 2015;3:294.

    file

    download